Clot-selective coronary thrombolysis with lowdose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator

This publication has 29 references indexed in Scilit:

• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: A pilot study
  Journal of the American College of Cardiology, 1989
• Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarction
  The American Journal of Cardiology, 1989
• Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator.
  Journal of Clinical Investigation, 1988
• Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction
  The American Journal of Cardiology, 1988
• Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction
  The American Journal of Cardiology, 1987
• Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate
  The American Journal of Cardiology, 1987
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
  New England Journal of Medicine, 1980
• The sulphite precipitation method for fibrinogen measurement; Its use on small samples in the presence of fibrinogen degradation products
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976